In light of the epidemiologic evidence linking PRL exposure to the development of ERα+ cancers in women, we investigated the phenotype of the mammary carcinomas that develop in NRL-PRL females, with regard to features defining clinical luminal tumors, including expression of the "ERα-associated signature", estrogen sensitivity, and activated signaling pathways. Here, ESR1 is linked to breast carcinoma.